Li Chen

6PUBLICATIONS
16CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
CD1d functions as a ligand for PIRA2 to drive macrophage activation in nonalcoholic fatty liver disease.

|Feb 24, 2026
Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.

Yabing Nan, Kunyu Wang, Menghan Hu

|May 15, 2025
Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunity.

Xiaosheng Tan, Xiangli Zhao, Zunsong Hu

|Mar 11, 2024
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery.

Qi Li, Cong Gao, Xinrui Zhao

|Feb 14, 2024
The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study.

Li Chen, Qiang Liu, Chunlei Tan

|Jan 29, 2020
Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.

Li Chen, Xiangyi Kong, Zhongzhao Wang

Pageof 1

Frequent Collaborators

2 joint publications

Xiaosheng Tan

2 joint publications

Peixiang Lan

1 joint publications

Xiangyi Kong

1 joint publications

Chunlei Tan